Pancreatic Cancer
Conditions
Interventions
None listed
Sponsors
Nagasaki University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients 18 years of age or older who have received dental care for perioperative oral management at Nagasaki University Hospital or Aichi-Gakuin University Hospital by December 28, 2024, from the date of approval by the hospital director, and who are scheduled to undergo pancreatic cancer surgery or chemotherapy on admission. 2. Patients who have given their consent to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Patients with severe xerostomia. 2. Pregnant or lactating patients. 3. Patients with severe cognitive impairment. 4. Other patients deemed inappropriate research subjects by the investigator or others. 5. Patients included in a previous study (Preliminary Study on the Usefulness of Saliva Checker for Cancer Risk Assessment (Saliva Checker), Approval No. 230821039).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Risk assessment of determined by Saliva Checker. The results are graded into four levels: A (very low risk), B (low risk), C (high risk), and D (very high risk) for lung, breast, colon, stomach, pancreatic, and oral cancer, respectively. | — |
Countries
Japan
Contacts
Public ContactSakiko Soutome
Nagasaki University Preventive Dentistry
Outcome results
None listed